The most reliable surface marker for the identification of colorectal cancer stem-like cells: A systematic review and meta-analysis
出版年份 2018 全文链接
标题
The most reliable surface marker for the identification of colorectal cancer stem-like cells: A systematic review and meta-analysis
作者
关键词
-
出版物
JOURNAL OF CELLULAR PHYSIOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2018-10-14
DOI
10.1002/jcp.27619
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- CD133 expression may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer stem cell hypothesis: a meta-analysis
- (2016) Yang Zhao et al. Oncotarget
- N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression
- (2015) Stephanie Holst et al. MOLECULAR & CELLULAR PROTEOMICS
- The prognostic value of CD44 expression in gastric cancer: A meta-Analysis
- (2014) Yansu Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach
- (2014) Xueyuan Cao et al. BMC GASTROENTEROLOGY
- Altered Tumor-Cell Glycosylation Promotes Metastasis
- (2014) Irina Häuselmann et al. Frontiers in Oncology
- CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer
- (2013) SEIYA SAITO et al. ONCOLOGY REPORTS
- CD133 Expression and the Prognosis of Colorectal Cancer: A Systematic Review and Meta-Analysis
- (2013) Shicai Chen et al. PLoS One
- Prognostic Value of CD166 Expression in Cancers of the Digestive System: A Systematic Review and Meta-Analysis
- (2013) Chao Ni et al. PLoS One
- CD133: A cancer stem cells marker, is used in colorectal cancers
- (2013) Fei Ren WORLD JOURNAL OF GASTROENTEROLOGY
- Prognostic role of CD133 expression in colorectal cancer: a meta-analysis
- (2012) Ke Wang et al. BMC CANCER
- Mutations in the Ras-Raf Axis Underlie the Prognostic Value of CD133 in Colorectal Cancer
- (2012) K. Kemper et al. CLINICAL CANCER RESEARCH
- CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges
- (2012) Philipp Grosse-Gehling et al. JOURNAL OF PATHOLOGY
- Colorectal Cancer Stem Cells
- (2012) Aristides G. Vaiopoulos et al. STEM CELLS
- CD133+, CD166+CD44+, and CD24+CD44+ Phenotypes Fail to Reliably Identify Cell Populations with Cancer Stem Cell Functional Features in Established Human Colorectal Cancer Cell Lines
- (2012) Manuele Giuseppe Muraro et al. Stem Cells Translational Medicine
- One renegade cancer stem cell?
- (2011) Tijana Borovski et al. CELL CYCLE
- Lessons from common markers of tumor-initiating cells in solid cancers
- (2011) Olivier Gires CELLULAR AND MOLECULAR LIFE SCIENCES
- Haematopoietic stem cell differentiation promotes the release of prominin-1/CD133-containing membrane vesicles-a role of the endocytic-exocytic pathway
- (2011) Nicola Bauer et al. EMBO Molecular Medicine
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- CD133 and membrane microdomains: Old facets for future hypotheses
- (2011) Christine A Fargeas WORLD JOURNAL OF GASTROENTEROLOGY
- Quantitative Analyses of CD133 Expression Facilitate Researches on Tumor Stem Cells
- (2010) Yongqiang Liao et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM and ALDH1 in colorectal cancer
- (2010) A Lugli et al. BRITISH JOURNAL OF CANCER
- The AC133 Epitope, but not the CD133 Protein, Is Lost upon Cancer Stem Cell Differentiation
- (2010) K. Kemper et al. CANCER RESEARCH
- Isolation and Propagation of a Human CD133- Colon Tumor-Derived Cell Line with Tumorigenic and Angiogenic Properties
- (2010) Nalú Navarro-Alvarez et al. CELL TRANSPLANTATION
- Complex Display of Putative Tumor Stem Cell Markers in the NCI60 Tumor Cell Line Panel
- (2010) Christina H. Stuelten et al. STEM CELLS
- Targeting the Mechanisms of Resistance to Chemotherapy and Radiotherapy with the Cancer Stem Cell Hypothesis
- (2010) Ryan Morrison et al. Journal of Oncology
- CD133 and nuclear β-catenin: The marker combination to detect high risk cases of low stage colorectal cancer
- (2009) David Horst et al. EUROPEAN JOURNAL OF CANCER
- Targeting CD133 antigen in cancer
- (2009) Gabriella Ferrandina et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- CD133 expression is not selective for tumor-initiating or radioresistant cell populations in the CRC cell line HCT-116
- (2009) Claudia Dittfeld et al. RADIOTHERAPY AND ONCOLOGY
- CD133+CD44+ Population Efficiently Enriches Colon Cancer Initiating Cells
- (2008) Naotsugu Haraguchi et al. ANNALS OF SURGICAL ONCOLOGY
- N-Glycans in cancer progression
- (2008) K. S Lau et al. GLYCOBIOLOGY
- Characterization of a subpopulation of colon cancer cells with stem cell-like properties
- (2008) Peter Chu et al. INTERNATIONAL JOURNAL OF CANCER
- Colonic and colorectal cancer stem cells: progress in the search for putative biomarkers
- (2008) Naomi D. Willis et al. JOURNAL OF ANATOMY
- Cancer stem cell markers in common cancers – therapeutic implications
- (2008) Thomas Klonisch et al. TRENDS IN MOLECULAR MEDICINE
- CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells
- (2007) Jian Wang et al. INTERNATIONAL JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started